Serum Retinol-Binding Protein Is More Highly Expressed in Visceral than in Subcutaneous Adipose Tissue and Is a Marker of Intra-abdominal Fat Mass
Top Cited Papers
Open Access
- 1 July 2007
- journal article
- research article
- Published by Elsevier in Cell Metabolism
- Vol. 6 (1) , 79-87
- https://doi.org/10.1016/j.cmet.2007.06.002
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01 DK-43051, K08 DK-69624, KFO 152, BL 580/3-1, BL 833/1-1)
- Deutsche Forschungsgemeinschaft (R01 DK-43051, K08 DK-69624, KFO 152, BL 580/3-1, BL 833/1-1)
- Takeda Pharmaceutical Company (R01 DK-43051, K08 DK-69624, KFO 152, BL 580/3-1, BL 833/1-1)
This publication has 43 references indexed in Scilit:
- Ethnicity, Insulin Resistance, and Inflammatory Adipokines in Women at High and Low Risk for Vascular DiseaseDiabetes Care, 2007
- Retinol binding protein 4 as a candidate gene for type 2 diabetes and prediabetic intermediate traitsMolecular Genetics and Metabolism, 2006
- Plasma Retinol-Binding Protein-4 Concentrations Are Elevated in Human Subjects With Impaired Glucose Tolerance and Type 2 DiabetesDiabetes Care, 2006
- Retinol-Binding Protein 4 in Human ObesityDiabetes, 2006
- Identification of a regulatory SNP in the retinol binding protein 4 gene associated with type 2 diabetes in MongoliaHuman Genetics, 2006
- Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetesNature, 2005
- Visfatin: A Protein Secreted by Visceral Fat That Mimics the Effects of InsulinScience, 2005
- Differences in Adiponectin Protein Expression: Effect of Fat Depots and Type 2 Diabetic StatusHormone and Metabolic Research, 2002
- Visceral fat and insulin resistance — causative or correlative?British Journal of Nutrition, 2000
- Metabolic Implications of Body Fat DistributionDiabetes Care, 1991